Larry Zaslow co-founded BioTheryX, Inc along with three Celgene scientists, including David Stirling, co-founder of Celgene. BioTheryX is a leader in protein degradation technology. In addition to being a founder, Mr. Zaslow also served as a director, president, and key executive over a period of fifteen years. During his tenure at BioTheryX Mr. Zaslow had primary responsibility for critical areas including strategic and operational planning, capital raising, financial planning/budget, corporate and business development, negotiation of licensing deals, investor and public relations. He helped position BioTheryX for its recent $100 million crossover round of financing and assembled a world class Scientific Advisory Board, including a Nobel Laureate.
Mr. Zaslow was a founding managing director of Amphion PLC, engaged in the formation, financing, management and development of life science and technology companies seeking to commercialize their intellectual property. He earned his BA in Economics from Brandeis University, and his MBA in Finance from the Columbia Business School.